NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

IL-10^−/− mice develop a less severe PCM associated with increased cellular immunity that results in decreased mortality rates. by Tânia A. Costa (440296)

Fe limitation decreases transcriptional regulation over the diel cycle in the model diatom <i>Thalassiosira pseudonana</i> - Fig 2 by Johanna A. L. Goldman (7372724)

Descriptive statistics of data presented in Tables 2–5. by Héctor Raúl Olivares-Sánchez (13014866)

Effect of exogenous reduced glutathione on hydrogen peroxide-induced cell death in PhS-treated cells. by Takeo Edamatsu (4885138)

Fig 5 - by Arjen Tilstra (6915227)

Dose-dependent effect of phenyl sulfate on total glutathione level. by Takeo Edamatsu (4885138)

Effect of hydrogen peroxide on cell death in BSO-treated cells. by Takeo Edamatsu (4885138)

Relationship between the delta VE/VT ratio and the mean decrease in oxygen saturation during the run. by Eva Bernardi (3897652)

Effects of protein-bound uremic solutes on total glutathione level. by Takeo Edamatsu (4885138)

Effect of exogenous reduced glutathione on cellular vulnerability to hydrogen peroxide in PhS-treated cells. by Takeo Edamatsu (4885138)

Effect of hydrogen peroxide on cellular viability in three uremic solutes-treated cells. by Takeo Edamatsu (4885138)

Effect of hydrogen peroxide on cellular viability in BSO-treated cells. by Takeo Edamatsu (4885138)

Decreased responsivity to mechanical stimuli during DRN 5-HT neurons photostimulation. by Guillaume P. Dugué (620333)

Expression of <i>OsMADS14</i>, <i>15</i>, <i>18</i> and <i>34</i> were decreased in <i>spPLDox</i> lines while increased in <i>spPLD-RNAi/Cas9</i> lines. by Li Qu (89645)

NO measurement after BPP-BrachyNH₂ addition on endothelium-intact rat aorta cross sections assessed by using a confocal scanning laser microscope. by Daniel Dias Rufino Arcanjo (536744)

Normalized whole brain volume change over 5 years using an SPM pipeline. by Renxin Chu (5169857)

Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

“…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”

Functional analysis of miR-545 and miR-374a. by Qi Zhao (124612)

Old rat serum present higher levels of pro-inflammatory cytokine. by María Paz Saldías (4430032)